Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)

BACKGROUND: Neuromyelitis optica (NMO) is a chronic autoimmune disease of the central nervous system (CNS). The main immunological feature of the disease is the presence of autoantibodies to Aquaporin 4 (AQP4+), identified in about 82 % of cases. Currently, there are no reliable biomarkers for monit...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaknin-Dembinsky, Adi, Charbit, Hanna, Brill, Livnat, Abramsky, Oded, Gur-Wahnon, Devorah, Ben-Dov, Iddo Z., Lavon, Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939003/
https://www.ncbi.nlm.nih.gov/pubmed/27393339
http://dx.doi.org/10.1186/s12974-016-0648-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939003/
https://www.ncbi.nlm.nih.gov/pubmed/27393339
http://dx.doi.org/10.1186/s12974-016-0648-x

Ejemplares similares